Shares of ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.01 and traded as high as $0.01. ProtoKinetix shares last traded at $0.01, with a volume of 93,000 shares changing hands.
ProtoKinetix Stock Performance
The firm has a 50-day moving average price of $0.01 and a 200-day moving average price of $0.01.
ProtoKinetix Company Profile
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.
Recommended Stories
- Five stocks we like better than ProtoKinetix
- What Are Dividend Challengers?
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Compound Interest and Why It Matters When Investing
- Alphabet’s Officially In A Bear Market—Time To Buy?
- 3 Best Fintech Stocks for a Portfolio Boost
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
